<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Studies have demonstrated that patients with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> have the highest oesophageal acid exposure profile, followed by <z:e sem="disease" ids="C0267055" disease_type="Disease or Syndrome" abbrv="">erosive oesophagitis</z:e> and non-erosive reflux disease patients, but the exact extent of overlap remains unknown </plain></SENT>
<SENT sid="1" pm="."><plain>AIM: To determine the extent of overlap in oesophageal acid exposure among the different <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">gastro-oesophageal reflux disease</z:e> groups </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: A total of 121 patients with <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">gastro-oesophageal reflux disease</z:e> underwent an upper endoscopy and were classified as having <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>, <z:e sem="disease" ids="C0267055" disease_type="Disease or Syndrome" abbrv="">erosive oesophagitis</z:e> and non-erosive reflux disease-<z:hpo ids='HP_0000001'>all</z:hpo> (non-erosive reflux disease-positive and functional heartburn) </plain></SENT>
<SENT sid="3" pm="."><plain>Subsequently, patients underwent pH testing and overlap in oesophageal acid exposure among the different <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">gastro-oesophageal reflux disease</z:e> groups was determined </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Of those enrolled, 24 had <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>, 30 erosive <z:e sem="disease" ids="C0014868" disease_type="Disease or Syndrome" abbrv="">oesophagitis</z:e> and 28 were non-erosive reflux disease-positive </plain></SENT>
<SENT sid="5" pm="."><plain>Mean oesophageal acid exposure time was 224.8 +/- 35, 134.3 +/- 21.9 and 141.3 +/- 19.8 min for <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>, <z:e sem="disease" ids="C0267055" disease_type="Disease or Syndrome" abbrv="">erosive oesophagitis</z:e> and non-erosive reflux disease-positive respectively </plain></SENT>
<SENT sid="6" pm="."><plain>Per cent overlap for total, upright and supine time between non-erosive reflux disease-positive and <z:e sem="disease" ids="C0267055" disease_type="Disease or Syndrome" abbrv="">erosive oesophagitis</z:e> was 47.4%, 64.7% and 81.8%, between <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> and <z:e sem="disease" ids="C0267055" disease_type="Disease or Syndrome" abbrv="">erosive oesophagitis</z:e> was 47.8%, 40.7% and 24%, and between <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> and non-erosive reflux disease-positive was 31.6%, 37.5% and 20.8% respectively </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Our study demonstrated a high oesophageal acid exposure overlap between patients with non-erosive reflux disease-positive and <z:e sem="disease" ids="C0267055" disease_type="Disease or Syndrome" abbrv="">erosive oesophagitis</z:e>, <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> and <z:e sem="disease" ids="C0267055" disease_type="Disease or Syndrome" abbrv="">erosive oesophagitis</z:e>, as well as <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> and non-erosive reflux disease-positive patients </plain></SENT>
</text></document>